Recent development in the design of sialyltransferase inhibitors

Xiaofang Wang, Li He Zhang, Xin Shan Ye

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.

Original languageEnglish (US)
Pages (from-to)32-47
Number of pages16
JournalMedicinal Research Reviews
Issue number1
StatePublished - Jan 2003
Externally publishedYes


  • Carbohydrate mimetics
  • Inhibitor
  • Review
  • Sialyltransferase
  • Structure-activity relationship

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Recent development in the design of sialyltransferase inhibitors'. Together they form a unique fingerprint.

Cite this